Document and Entity Information
Document and Entity Information - shares | 3 Months Ended | |
Mar. 31, 2021 | Jul. 22, 2021 | |
Document Information [Line Items] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Document Period End Date | Mar. 31, 2021 | |
Entity File Number | 001-40167 | |
Entity Registrant Name | TRIBE CAPITAL GROWTH CORP I | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 85-3901431 | |
Entity Address, Address Line One | 2700 19th Street | |
Entity Address, City or Town | San Francisco | |
Entity Address State Or Province | CA | |
Entity Address, Postal Zip Code | 94110 | |
City Area Code | 619 | |
Local Phone Number | 567-9955 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Entity Shell Company | true | |
Entity Central Index Key | 0001831874 | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2021 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | false | |
Transition Report | false | |
Units, each consisting of one share of Class A Common Stock and one-half of one Warrant | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Units, each consisting of one share of Class A Common Stock and one-fourth of one Redeemable Warrant | |
Trading Symbol | ATVCU | |
Security Exchange Name | NASDAQ | |
Class A Common Stock | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Class A Common Stock, par value $0.0001 per share | |
Trading Symbol | ATVC | |
Security Exchange Name | NASDAQ | |
Entity Common Stock, Shares Outstanding | 27,600,000 | |
Redeemable Warrants Exercisable For Class Common Stock | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 | |
Trading Symbol | ATVCW | |
Security Exchange Name | NASDAQ | |
Class B Common Stock | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 6,900,000 |
BALANCE SHEET
BALANCE SHEET - USD ($) | Mar. 31, 2021 | Dec. 31, 2020 |
Current assets | ||
Cash | $ 999,748 | |
Prepaid expenses | 438,691 | |
Deferred offering costs | 1,061 | $ 298,962 |
Total current assets | 1,439,500 | 298,962 |
Marketable securities held in Trust Account | 276,000,000 | |
Total Assets | 277,439,500 | |
Assets total | 298,962 | |
Current liabilities | ||
Accrued offering costs | 262,764 | |
Accounts payable and accrued expenses | 173,464 | |
Due to related party | 38,252 | 12,500 |
Franchise tax payable | 50,000 | |
Total Liabilities | 261,716 | 275,264 |
Deferred underwriting fee payable | 9,660,000 | |
Warranty liability | 18,981,991 | |
Total Liabilities | 28,903,707 | 275,264 |
Commitments | ||
Class A common stock subject to possible redemption, 24,353,579 and 0 shares at $10.00 redemption value at March 31, 2021 and December 31, 2020, respectively | 243,535,790 | |
Stockholder's Equity | ||
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | ||
Additional paid-in capital | 6,963,704 | 24,310 |
Accumulated deficit | (1,964,715) | (1,302) |
Total Stockholder's Equity | 5,000,003 | 23,698 |
TOTAL LIABILITIES AND STOCKHOLDER'S EQUITY | 277,439,500 | 298,962 |
Class A Common Stock | ||
Stockholder's Equity | ||
Total Stockholder's Equity | 324 | |
Class A Common Stock Not Subject to Redemption | ||
Stockholder's Equity | ||
Common stock | 324 | |
Class B Common Stock | ||
Stockholder's Equity | ||
Common stock | 690 | 690 |
Total Stockholder's Equity | $ 690 | $ 690 |
BALANCE SHEET (Parenthetical)
BALANCE SHEET (Parenthetical) - $ / shares | Mar. 31, 2021 | Dec. 31, 2020 |
Preferred stock, par value, (per share) | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized | 1,000,000 | 1,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Class A Common Stock | ||
Common shares, par value, (per share) | $ 0.0001 | $ 0.0001 |
Common shares, shares authorized | 280,000,000 | 280,000,000 |
Common shares, shares issued | 3,246,421 | 0 |
Common shares, shares outstanding | 3,246,421 | 0 |
Stock subject to possible redemption | 24,353,579 | 0 |
Stock subject to possible redemption redemption value per share | $ 10 | $ 10 |
Class A Common Stock Subject to Redemption | ||
Temporary equity, shares issued | 24,353,579 | 0 |
Class A Common Stock Not Subject to Redemption | ||
Common shares, par value, (per share) | $ 0.0001 | $ 0.0001 |
Common shares, shares authorized | 280,000,000 | 280,000,000 |
Common shares, shares issued | 3,246,421 | |
Common shares, shares outstanding | 3,246,421 | 0 |
Class B Common Stock | ||
Common shares, par value, (per share) | $ 0.0001 | $ 0.0001 |
Common shares, shares authorized | 20,000,000 | 20,000,000 |
Common shares, shares issued | 6,900,000 | 6,900,000 |
Common shares, shares outstanding | 6,900,000 | 6,900,000 |
CONDENSED STATEMENTS OF OPERATI
CONDENSED STATEMENTS OF OPERATIONS | 3 Months Ended |
Mar. 31, 2021USD ($)$ / sharesshares | |
Formation and operating costs | $ 398,021 |
Loss from operations | (398,021) |
Other income/(expense) | |
Unrealized loss on change in fair value of warrants | (659,945) |
Transaction costs | (606,622) |
Excess of fair value of Private Warrants | (298,825) |
Total other expense | (1,565,392) |
Net loss | $ (1,963,413) |
Weighted average shares outstanding, basic and diluted | shares | 6,900,000 |
Basic and diluted net income (loss) per common share | $ / shares | $ (0.28) |
Class A Common Stock Subject to Redemption | |
Other income/(expense) | |
Weighted average shares outstanding, basic and diluted | shares | 27,600,000 |
Basic and diluted net income (loss) per common share | $ / shares | $ 0 |
CONDENSED STATEMENTS OF OPERA_2
CONDENSED STATEMENTS OF OPERATIONS (Parenthetical) - shares | Mar. 31, 2021 | Dec. 31, 2020 |
Class A Common Stock | ||
Stock subject to possible redemption | 24,353,579 | 0 |
CONDENSED STATEMENTS OF CHANGES
CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - 3 months ended Mar. 31, 2021 - USD ($) | Class A Common Stock | Class B Common Stock | Additional Paid-in Capital | Accumulated Deficit | Total |
Balance at the beginning at Dec. 31, 2020 | $ 690 | $ 24,310 | $ (1,302) | $ 23,698 | |
Balance at the beginning (in shares) at Dec. 31, 2020 | 6,900,000 | ||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Sale of 27,600,000 Units on March 9, 2021 net of warrant fair value | $ 2,760 | 265,494,019 | 265,496,779 | ||
Sale of 27,600,000 Units on March 9, 2021 net of warrant fair value (in shares) | 27,600,000 | ||||
Offering costs | (15,021,271) | (15,021,271) | |||
Net loss | (1,963,413) | (1,963,413) | |||
The maximum number of redeemable shares | $ (2,436) | (243,533,354) | (243,535,790) | ||
The maximum number of redeemable shares (in shares) | (24,353,579) | ||||
Balance at the end at Mar. 31, 2021 | $ 324 | $ 690 | $ 6,963,704 | $ (1,964,715) | $ 5,000,003 |
Balance at the end (in shares) at Mar. 31, 2021 | 3,246,421 | 6,900,000 |
CONDENSED STATEMENTS OF CHANG_2
CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) - shares | Mar. 09, 2021 | Apr. 12, 2021 | Mar. 31, 2021 |
Warrants | |||
Sale of Units | 27,600,000 | ||
Private Warrants | |||
Sale of Private Placement Warrants (in shares) | 6,900,000 | 5,013,333 | |
Over-allotment option | |||
Sale of Units | 3,600,000 | ||
Private Placement | |||
Sale of Private Placement Warrants (in shares) | 5,013,333 | ||
Private Placement | Warrants | |||
Sale of Private Placement Warrants (in shares) | 1 |
CONDENSED STATEMENT OF CASH FLO
CONDENSED STATEMENT OF CASH FLOWS | 3 Months Ended |
Mar. 31, 2021USD ($) | |
Cash Flows from Operating Activities: | |
Net loss | $ (1,963,413) |
Adjustments to reconcile net loss to net cash used in operating activities: | |
Excess of fair value of Private Warrants | 298,825 |
Change in fair value of warrant liabilities | 659,945 |
Transaction costs | 606,622 |
Changes in operating assets and liabilities | |
Prepaid assets | (438,691) |
Due from Sponsor | (1,061) |
Taxes payable | 50,000 |
Due to related party | 25,752 |
Accounts payable and accrued expenses | 209,662 |
Net cash used in operating activities | (552,359) |
Cash Flows from Investing Activities: | |
Investments and marketable securities held in Trust | (276,000,000) |
Net cash used in investing activities | (276,000,000) |
Cash Flows from Financing Activities: | |
Proceeds from sale of Units, net of offering costs | 275,552,107 |
Proceeds from issuance of Private Warrants | 7,520,000 |
Payment of underwriter discount | (5,520,000) |
Net cash provided by financing activities | 277,552,107 |
Net Change in Cash | 999,748 |
Cash, end of period | 999,748 |
Supplemental Disclosure of Non-cash Operating and Financing Activities: | |
Warrant liability | 18,322,046 |
Class A ordinary shares subject to possible redemption | 243,535,790 |
Deferred underwriters' discount payable charged to additional paid in capital | $ 14,000,000 |
Organization and Business Opera
Organization and Business Operations | 3 Months Ended |
Mar. 31, 2021 | |
Organization and Business Operations | |
Organization and Business Operations | Note 1 — Organization and Business Operations Tribe Capital Growth Corp I (the “Company”) is a blank check company incorporated as a Delaware corporation on November 5, 2020. The Company was incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company has not selected any specific Business Combination target and it has not, nor has anyone on its behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with the Company. As of March 31, 2021, the Company had not commenced any operations. All activity for the period from December 31, 2020 through March 31, 2021 relates to the Company’s formation and the initial public offering described below (the “IPO”). The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO and unrealized gains and losses on the change in fair value of its warrants. The Company has selected December 31 as its fiscal year end. The Company’s sponsor is Tribe Arrow Holdings I, LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s IPO was declared effective on March 4, 2021 (the “Effective Date”). On March 9, 2021, the Company consummated the IPO of 27,600,000 units (the “Units”), which includes the full exercise by the underwriters of the over-allotment option to purchase an additional 3,600,000 Units, at $10.00 per Unit, generating gross proceeds of $276,000,000, which is discussed in Note 3. Simultaneously with the closing of the IPO, the Company consummated the sale of 5,013,333 warrants (the “Private Warrants”) to the Sponsor and Cantor Fitzgerald & Co., at a price of $1.50 per Private Warrant, generating gross proceeds of $7,520,000, which is discussed in Note 4. Each warrant (including the Private Warrants and the warrants included as part of the Units) entitles the holder to purchase one share of common stock at a price of $11.50 per share. Transaction costs for the IPO amounted to $15,627,893 consisting of $5,520,000 of underwriting discount, $9,660,000 of deferred underwriting discount, and $447,893 of other offering costs. Of the transaction costs, $606,622 is included in transaction costs on the statement of operations and $15,021,271 is included in equity. Following the closing of the IPO on March 9, 2021, $276,000,000 (approximately $10.00 per Unit) from the net proceeds of the sale of the Units in the IPO, including the proceeds from the sale of the Private Warrants, was deposited in a trust account (“Trust Account”), located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and will be invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay taxes, the proceeds from the IPO and the sale of the Private Warrants will not be released from the Trust Account until the earliest of (i) the completion of initial Business Combination, (ii) the redemption of the Company’s public shares if the Company does not complete an initial Business Combination within 24 months from the closing of the IPO, subject to applicable law, or (iii) the redemption of the Company’s public shares properly submitted in connection with a stockholder vote to amend its amended and restated certificate of incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of its public shares if the Company has not consummated an initial Business Combination within 24 months from the closing of the IPO or with respect to any other material provisions relating to stockholders’ rights or pre-initial Business Combination activity. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public stockholders. The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) without a stockholder vote by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed Business Combination or conduct a tender offer will be made by the Company, in its sole discretion. The stockholders will be entitled to redeem their shares for a pro rata share of the aggregate amount then on deposit in the Trust Account calculated as of two the initial Business Combination, including interest earned on the funds held in the Trust Account (which interest shall be net of taxes payable), divided by the number of then outstanding public shares, subject to the limitations and on the conditions described herein. The amount in the Trust Account is initially approximately $10.00 per public share. The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the representative of the underwriters. The shares of common stock subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. The Company will have only 24 months from the closing of the IPO to complete the initial Business Combination (the “Combination Period”). However, if the Company is unable to complete the initial Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten The Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to any Founder Shares and public shares they hold in connection with the completion of the initial Business Combination, (ii) waive their redemption rights with respect to their Founder Shares and public shares in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation, (iii) waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares they hold if the Company fails to complete the initial Business Combination within the Combination Period, and (iv) vote any Founder Shares held by them and any public shares purchased during or after the IPO in favor of the initial Business Combination. The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share, due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. Liquidity and Capital Resources The Company’s liquidity needs up to March 9, 2021 (the date of the IPO) had been satisfied through a capital contribution from the Sponsor of $25,000 (see Note 5) for the Founder Shares and the loan under an unsecured promissory note from the Sponsor for $300,000 (see Note 5). The promissory note from the Sponsor was fully repaid on March 9, 2021, in the amount of $300,000. In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 5). At March 31, 2021, there was $38,252 outstanding under the Working Capital Loans. The Company consummated its IPO on March 9, 2021. As of March 31, 2021, the Company had approximately $1.0 million in its operating bank account, and working capital of approximately $1.2 million. Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. |
Revision of Financial Statement
Revision of Financial Statements | 3 Months Ended |
Mar. 31, 2021 | |
Revision of Financial Statements | |
Revision of Financial Statements | Note 2 Revision of Financial Statements On April 12, 2021, the Staff of the Securities and Exchange Commission issued a statement regarding the accounting and reporting considerations for warrants issued by special purpose acquisition companies entitled "Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies ("SPACs")" (the "SEC Statement"). Specifically, the SEC Statement focused on certain settlement terms and provisions related to certain tender offers following a Business Combination, which terms are similar to those contained in the warrant agreement between the Company and Continental Stock Transfer & Trust Company, as warrant agent (the "Warrant Agreement"). As a result of the SEC Statement, the Company reevaluated the accounting treatment of (i) the 6,900,000 public warrants that were included in the Units issued by the Company in its IPO and (ii) the 5,013,333 Private Warrants (see Note 4, Note 5 and Note 8). The Company previously accounted for the public warrants and the Private Warrants as components of equity. In further consideration of the guidance in Accounting Standards Codification ("ASC") 815-40, Derivatives and Hedging; Contracts in Entity's Own Equity, the Company concluded that a provision in the Warrant Agreement related to certain tender or exchange offers precludes the Warrants from being accounted for as components of equity. As the Warrants meet the definition of a derivative as contemplated in ASC 815, the Warrants should be recorded as derivative liabilities on the Company’s balance sheet and measured at fair value at inception (on the date of the IPO) and at each reporting date in accordance with ASC 820, Fair Value Measurement, with changes in fair value recognized in the statement of operations in the period of change. In the Company’s 8-K dated March 15, 2021 the Company reported the value of the warrants in equity. After consultation with the Company's independent registered public accounting firm, the Company's management and the audit committee of the Company's Board of Directors concluded that it is appropriate to revise the accounting of the Company’s public warrants and the Private Warrants. The following tables summarize the effect had the financial statements been restated on each financial statement line item as of the date indicated: As Previously Reported Adjustment As restated Balance Sheet at March 9, 2021 Warrant liability $ — $ 18,322,046 $ 18,322,046 Total Liabilities 10,412,720 18,322,046 28,734,766 Class A common stock subject to possible redemption, 262,680,960 (18,322,050) 244,358,910 Class A common stock 133 183 316 Additional paid-in capital 5,002,908 918,674 5,921,582 Accumulated deficit (3,728) (918,853) (922,581) Total Stockholders’ Equity $ 5,000,003 4 5,000,007 |
Significant Accounting Policies
Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2021 | |
Significant Accounting Policies | |
Significant Accounting Policies | Note 3 — Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s final prospectus related to the IPO dated March 4, 2021 and filed with the SEC on March 8, 2021, which contains the Company’s December 31, 2020 audited financial statements and notes thereto. The interim results for the three months ended March 31, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods. Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had approximately $1.0 million in cash and did not have any cash equivalents as of March 31, 2021. Cash Held in Trust Account At March 9, 2021, the Company had $276,000,000 in cash held in the Trust Account. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Common Stock Subject to Possible Redemption The Company accounts for its shares of common stock subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, shares of common stock are classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet. Net Loss Per Share Net loss per share of common stock is computed by dividing net loss by the weighted average number of shares of common stock outstanding for each of the periods. The calculation of diluted net loss per share of common stock does not consider the effect of the warrants issued in connection with the IPO since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The Company’s statements of operations include a presentation of net income per share for Class A Common Stock subject to possible redemption in a manner similar to the two-class method of loss per share of common stock. Net income per share of Class A common stock, basic and diluted, for redeemable Class A Common Stock is calculated by dividing the interest income earned on the Trust Account, by the weighted average number of shares of redeemable Class A Common Stock outstanding since original issuance. Net loss per share of common stock, basic and diluted, for non-redeemable Class A and Class B Common Stock is calculated by dividing the net loss, adjusted for income attributable to redeemable Class A Common Stock, by the weighted average number of shares of non-redeemable Class A and Class B Common Stock outstanding for the periods. Non-redeemable Class B Common Stock includes the Founder Shares as such shares of common stock does not have any redemption features and does not participate in the income earned on the Trust Account. For the three months ended March 31, 2021 Common stock subject to possible redemption Numerator: Net income allocable to Class A common stock subject to possible redemption Accretion of interest income on cash held in trust $ 0 Less: interest available to be withdrawn for payment of taxes (0) Net income allocable to Class A common stock subject to possible redemption $ — Denominator: Weighted Average Redeemable Class A common stock Redeemable Class A Common Stock, Basic and Diluted 27,600,000 Basic and Diluted net income per share, Redeemable Class A Common Stock $ 0.00 Non-Redeemable Common Stock Numerator: Net Income minus Redeemable Net Earnings Net Loss $ (1,963,413) Redeemable Net Earnings 0 Non-Redeemable Net Loss $ (1,963,413) Denominator: Weighted Average Non-Redeemable Common Stock Basic and diluted weighted average shares outstanding, common stock 6,900,000 Basic and diluted net loss per share, common stock $ (0.28) Offering Costs The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A—“Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO. Offering costs are charged to stockholders’ equity or the statement of operations based on the relative value of the Public Warrants to the proceeds received from the Units sold upon the completion of the IPO. Accordingly, as of March 31, 2021, offering costs totaling $15,627,893 (consisting of $5,520,000 of underwriting discount, $9,660,000 of deferred underwriting discount, and $447,893 of other offering costs) were recognized with $606,622, which was allocated to the public warrants and Private Warrants and included in the statement of operations, and $15,627,893 included in stockholders’ equity. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. Derivative instruments are recorded at fair value on the grant date and re-valued at each reporting date, with changes in the fair value reported in the statements of operations. Derivative assets and liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Company has determined the warrants are a derivative instrument. FASB ASC 470-20, Debt with Conversion and Other Options addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate IPO proceeds from the Units between Class A common stock and warrants, using the residual method by allocating IPO proceeds first to fair value of the warrants and then the Class A common stock. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. Income Taxes The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. The deferred tax assets were deemed to be immaterial as of March 31, 2021. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 9, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income tax examinations by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The provision for income taxes was deemed to be immaterial for the period from December 31, 2020 through March 31, 2021. Recent Accounting Pronouncements In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt --debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging --Contracts in Entity' Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity' Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on January 1, 2021. Adoption of the ASU did not impact the Company's financial position, results of operations or cash flows. The Company's management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements. Risks and Uncertainties Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. |
Initial Public Offering
Initial Public Offering | 3 Months Ended |
Mar. 31, 2021 | |
Initial Public Offering | |
Initial Public Offering | Note 4 — Initial Public Offering On March 9, 2021, the Company sold 27,600,000 units, which includes 3,600,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option, at a purchase price of $10.00 per Unit, generating gross proceeds of $276,000,000. Each Unit consists of one share of Class A common stock, and one The Company paid an underwriting fee at the closing of the IPO of $5,520,000. As of March 9, 2021, an additional fee of $9,660,000 (see Note 6) was deferred and will become payable upon the Company’s completion of an initial Business Combination. The deferred portion of the fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event the Company completes its initial Business Combination. Warrants The warrants will become exercisable on the later of 12 months from the closing of the IPO or 30 days after the completion of its initial Business Combination, and will expire five years after the completion of the Company’s initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. The Company has agreed that as soon as practicable, but in no event later than fifteen (15) business days after the closing of the initial Business Combination, it will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A common stock issuable upon exercise of the warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the Class A common stock issuable upon exercise of the warrants is not effective by the sixtieth (60th) business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company’s Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. Once the warrants become exercisable, the Company may call the warrants for redemption for cash: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon not less than 30 days’ prior written notice of redemption to each warrant holder (the “30-day redemption period”); and ● if, and only if, the closing price of the common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing once the warrants become exercisable and ending three business days before the Company sends to the notice of redemption to the warrant holders. If and when the warrants become redeemable by the Company for cash, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. |
Private Placement
Private Placement | 3 Months Ended |
Mar. 31, 2021 | |
Private Placement | |
Private Placement | Note 5 — Private Placement Simultaneously with the closing of the IPO, the Sponsor and Cantor purchased an aggregate of 5,013,333 Private Warrants at a price of $1.50 per Private Warrant, for an aggregate purchase price of $7,520,000, in a private placement. Each Private Warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share. A portion of the proceeds from the private placement was added to the proceeds from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Warrants will expire worthless. The Private Warrants are identical to the public warrants included as part of the Units sold in the IPO except that they will be non-redeemable and exercisable on a cashless basis for as long as the Private Warrants are held by the Sponsor or Cantor Fitzgerald & Co. (“Cantor”) the representative of the underwriters or its permitted transferees. Additionally, for so long as the Private Warrants are held by Cantor or its designees or affiliates, they may not be exercised after five years from the commencement of sales of the IPO. |
Related Party Transactions
Related Party Transactions | 3 Months Ended |
Mar. 31, 2021 | |
Related Party Transactions | |
Related Party Transactions | Note 6 — Related Party Transactions Founder Shares In December 2020, the Sponsor paid $25,000, or approximately $0.004 per share, to cover certain offering costs in consideration for 5,750,000 Class B common stock, par value $0.0001 (the “Founder Shares”). In February 2021, the Company effected a stock dividend of 0.2 shares for each share of Class B common stock outstanding, resulting in the Sponsor holding an aggregate of 6,900,000 Founder Shares (up to an aggregate of 900,000 of which were subject to forfeiture depending on the extent to which the underwriters’ over-allotment option is exercised). All shares and associated amounts have been retroactively restated to reflect the stock dividend. As a result of the underwriters’ election to fully exercise their over-allotment option, the 900,000 shares were no longer subject to forfeiture. The Sponsor has agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination and (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction after the initial Business Combination that results in all of its stockholders having the right to exchange their Class A common stock for cash, securities or other property (the “lock-up”). Notwithstanding the foregoing, if the closing price of the Company's Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, the Founder Shares will be released from the lock-up. Promissory Note — Related Party On December 31, 2020, the Sponsor agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the IPO. These loans are non-interest bearing, unsecured and are due at the earlier of June 30, 2021 or the closing of the Proposed Public Offering. The loan was to be repaid upon the closing of the IPO out of the $1,000,000 of offering proceeds that has been allocated to the payment of offering expenses. As of March 9, 2021, the Company had fully repaid the balance of the promissory note. Related Party Loans In addition, in order to fund working capital deficiencies or finance transaction costs in connection with an intended Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required on a non-interest bearing basis (“Working Capital Loans”). If the Company completes the initial Business Combination, the Company would repay the Working Capital Loans. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant at the option of the lender. Such warrants would be identical to the Private Warrants. As of March 31, 2021, the Company had $38,252 in borrowings under the Working Capital Loans. Administrative Service Fee Subsequent to the closing of the IPO, the Company will pay an affiliate of the Sponsor $10,000 per month for office space, secretarial and administrative services provided to members of the Company’s management team. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2021 | |
Commitments and Contingencies | |
Commitments and Contingencies | Note 7 — Commitments and Contingencies Registration Rights The holders of the (i) Founder Shares, which were issued in a private placement prior to the closing of the IPO, (ii) Private Warrants, which were issued in a private placement simultaneously with the closing of the IPO and the shares of Class A common stock underlying such Private Warrants and (iii) Private Warrants that may be issued upon conversion of Working Capital Loans will have registration rights to require the Company to register a sale of any of the Company’s securities held by them pursuant to a registration rights agreement to be signed prior to or on the Effective Date. The holders of these securities are entitled to make up to three demands, excluding Form S-3 demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of its initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters are entitled to a deferred underwriting discount of 3.5% ($9,660,000) of the gross proceeds of the IPO upon the completion of the Company’s initial Business Combination. |
Stockholder's Equity
Stockholder's Equity | 3 Months Ended |
Mar. 31, 2021 | |
Stockholder's Equity | |
Stockholder's Equity | Note 8 — Stockholder’s Equity Preferred stock no outstanding Class A Common Stock outstanding excluding Class B Common Stock Stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the Company’s stockholders except as required by law. Unless specified in the Company's amended and restated certificate of incorporation, or as required by applicable provisions of the DGCL or applicable stock exchange rules, the affirmative vote of a majority of the Company's shares of common stock that are voted is required to approve any such matter voted on by its stockholders. The Class B common stock will automatically convert into Class A common stock upon the consummation of the initial Business Combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of Class A common stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the total number of Class A common stock outstanding after such conversion, including the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding (i) any shares of Class A common stock redeemed by public stockholders in connection with the initial Business Combination and (ii) any Class A common stock or equity-linked securities exercisable for or convertible into Class A common stock issued, or to be issued, to any seller in the initial Business Combination and any Private Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis. |
Recurring Fair Value Measuremen
Recurring Fair Value Measurements | 3 Months Ended |
Mar. 31, 2021 | |
Recurring Fair Value Measurements | |
Recurring Fair Value Measurements | Note 9 —Recurring Fair Value Measurements Investment Held in Trust Account As of March 31, 2021, the investments in the Company’s Trust Account consisted of $276,000,000 in cash. Fair values of its investments are classified as Level 1 utilizing quoted prices (unadjusted) in active markets for identical assets. Warrant Liability At March 31, 2021, the Company’s warrants liability was valued at $18,981,991. Under the guidance in ASC 815-40 the warrants do not meet the criteria for equity treatment. As such, the warrants must be recorded on the balance sheet at fair value. This valuation is subject to re-measurement at each balance sheet date. With each re-measurement, the warrant valuation will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations. Recurring Fair Value Measurements All of the Company’s permitted investments consist of cash. Fair values of these investments are determined by Level 1 inputs utilizing quoted prices (unadjusted) in active markets for identical assets. The Company’s warrant liability for the Warrants is based on a valuation model utilizing management judgment and pricing inputs from observable and unobservable markets with less volume and transaction frequency than active markets. Significant deviations from these estimates and inputs could result in a material change in fair value. The fair values of the Private Placement and Public Warrant liabilities are classified within Level 3 of the fair value hierarchy. For the period ending March 31, 2021 there were to transfers into or out of Level 1, Level 2 or Level 3 classification. The following table presents fair value information as of March 31, 2021 of the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. Quoted Prices in Significant Other Significant Other Carrying Active Markets Observable Inputs Unobservable Inputs Value (Level 1) (Level 2) (Level 3) Assets: Investments held in Trust Account – U.S. Treasury Bills 0 $ 276,000,000 $ — $ — Liabilities: Private Warrants — — — 8,092,670 Public Warrants 1 — — 10,889,321 Measurement The Company established the initial fair value for the warrants on March 9, 2021, the date of the consummation of the IPO. On March 31, 2021 the fair value was remeasured. For both periods, neither the public warrants nor the Private Warrants were separately traded on an open market. As such, the Company used a Monte Carlo simulation model to value the warrants. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one share of Class A common stock and one-fourth of one public warrant), (ii) the sale of Private Warrants, and (iii) the issuance of Class B common stock, first to the warrants based on their fair values as determined at initial measurement, with the remaining proceeds allocated to Class A common stock subject to possible redemption (temporary equity), Class A common stock (permanent equity) and Class B common stock (permanent equity) based on their relative fair values at the initial measurement date. The warrants were classified within Level 3 of the fair value hierarchy at the measurement dates due to the use of unobservable inputs. The key inputs into the Monte Carlo simulation model for the Warrants were as follows at initial measurement and at March 31, 2021: March 9, 2021 (Initial Input Measurement) March 31, 2021 Risk-free interest rate 1.09 % 1.22 % Expected term (years) 6.31 6.25 Expected volatility 24.3 % 24.4 % Exercise price $ 11.50 $ 11.50 The change in the fair value of the warrant liabilities for the period ended March 31, 2021 is summarized as follows: Fair value at issuance March 9 2021 $ 18,322,046 Change in fair value 659,945 Fair Value at March 31, 2021 $ 18,981,991 |
Subsequent Events
Subsequent Events | 3 Months Ended |
Mar. 31, 2021 | |
Subsequent Events | |
Subsequent Events | Note 10 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. |
Significant Accounting Polici_2
Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2021 | |
Significant Accounting Policies | |
Basis of Presentation | Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s final prospectus related to the IPO dated March 4, 2021 and filed with the SEC on March 8, 2021, which contains the Company’s December 31, 2020 audited financial statements and notes thereto. The interim results for the three months ended March 31, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods. |
Emerging Growth Company Status | Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had approximately $1.0 million in cash and did not have any cash equivalents as of March 31, 2021. |
Cash Held in Trust Account | Cash Held in Trust Account At March 9, 2021, the Company had $276,000,000 in cash held in the Trust Account. |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. |
Common Stock Subject to Possible Redemption | Common Stock Subject to Possible Redemption The Company accounts for its shares of common stock subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, shares of common stock are classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet. |
Net Loss Per Share | Net Loss Per Share Net loss per share of common stock is computed by dividing net loss by the weighted average number of shares of common stock outstanding for each of the periods. The calculation of diluted net loss per share of common stock does not consider the effect of the warrants issued in connection with the IPO since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The Company’s statements of operations include a presentation of net income per share for Class A Common Stock subject to possible redemption in a manner similar to the two-class method of loss per share of common stock. Net income per share of Class A common stock, basic and diluted, for redeemable Class A Common Stock is calculated by dividing the interest income earned on the Trust Account, by the weighted average number of shares of redeemable Class A Common Stock outstanding since original issuance. Net loss per share of common stock, basic and diluted, for non-redeemable Class A and Class B Common Stock is calculated by dividing the net loss, adjusted for income attributable to redeemable Class A Common Stock, by the weighted average number of shares of non-redeemable Class A and Class B Common Stock outstanding for the periods. Non-redeemable Class B Common Stock includes the Founder Shares as such shares of common stock does not have any redemption features and does not participate in the income earned on the Trust Account. For the three months ended March 31, 2021 Common stock subject to possible redemption Numerator: Net income allocable to Class A common stock subject to possible redemption Accretion of interest income on cash held in trust $ 0 Less: interest available to be withdrawn for payment of taxes (0) Net income allocable to Class A common stock subject to possible redemption $ — Denominator: Weighted Average Redeemable Class A common stock Redeemable Class A Common Stock, Basic and Diluted 27,600,000 Basic and Diluted net income per share, Redeemable Class A Common Stock $ 0.00 Non-Redeemable Common Stock Numerator: Net Income minus Redeemable Net Earnings Net Loss $ (1,963,413) Redeemable Net Earnings 0 Non-Redeemable Net Loss $ (1,963,413) Denominator: Weighted Average Non-Redeemable Common Stock Basic and diluted weighted average shares outstanding, common stock 6,900,000 Basic and diluted net loss per share, common stock $ (0.28) |
Offering Costs | Offering Costs The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A—“Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO. Offering costs are charged to stockholders’ equity or the statement of operations based on the relative value of the Public Warrants to the proceeds received from the Units sold upon the completion of the IPO. Accordingly, as of March 31, 2021, offering costs totaling $15,627,893 (consisting of $5,520,000 of underwriting discount, $9,660,000 of deferred underwriting discount, and $447,893 of other offering costs) were recognized with $606,622, which was allocated to the public warrants and Private Warrants and included in the statement of operations, and $15,627,893 included in stockholders’ equity. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. |
Derivative Financial Instruments | Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. Derivative instruments are recorded at fair value on the grant date and re-valued at each reporting date, with changes in the fair value reported in the statements of operations. Derivative assets and liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Company has determined the warrants are a derivative instrument. FASB ASC 470-20, Debt with Conversion and Other Options addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate IPO proceeds from the Units between Class A common stock and warrants, using the residual method by allocating IPO proceeds first to fair value of the warrants and then the Class A common stock. |
Fair Value Measurements | Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
Income Taxes | Income Taxes The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. The deferred tax assets were deemed to be immaterial as of March 31, 2021. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 9, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income tax examinations by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The provision for income taxes was deemed to be immaterial for the period from December 31, 2020 through March 31, 2021. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt --debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging --Contracts in Entity' Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity' Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on January 1, 2021. Adoption of the ASU did not impact the Company's financial position, results of operations or cash flows. The Company's management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements. |
Risks and Uncertainties | Risks and Uncertainties Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. |
Revision of Financial Stateme_2
Revision of Financial Statements (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Revision of Financial Statements | |
Schedule of financial statements been restated | As Previously Reported Adjustment As restated Balance Sheet at March 9, 2021 Warrant liability $ — $ 18,322,046 $ 18,322,046 Total Liabilities 10,412,720 18,322,046 28,734,766 Class A common stock subject to possible redemption, 262,680,960 (18,322,050) 244,358,910 Class A common stock 133 183 316 Additional paid-in capital 5,002,908 918,674 5,921,582 Accumulated deficit (3,728) (918,853) (922,581) Total Stockholders’ Equity $ 5,000,003 4 5,000,007 |
Significant Accounting Polici_3
Significant Accounting Policies (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Significant Accounting Policies | |
Reconciliation of Net Loss per Common Share | For the three months ended March 31, 2021 Common stock subject to possible redemption Numerator: Net income allocable to Class A common stock subject to possible redemption Accretion of interest income on cash held in trust $ 0 Less: interest available to be withdrawn for payment of taxes (0) Net income allocable to Class A common stock subject to possible redemption $ — Denominator: Weighted Average Redeemable Class A common stock Redeemable Class A Common Stock, Basic and Diluted 27,600,000 Basic and Diluted net income per share, Redeemable Class A Common Stock $ 0.00 Non-Redeemable Common Stock Numerator: Net Income minus Redeemable Net Earnings Net Loss $ (1,963,413) Redeemable Net Earnings 0 Non-Redeemable Net Loss $ (1,963,413) Denominator: Weighted Average Non-Redeemable Common Stock Basic and diluted weighted average shares outstanding, common stock 6,900,000 Basic and diluted net loss per share, common stock $ (0.28) |
Recurring Fair Value Measurem_2
Recurring Fair Value Measurements (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Recurring Fair Value Measurements | |
Schedule of company's assets that are measured at fair value on a recurring basis | Quoted Prices in Significant Other Significant Other Carrying Active Markets Observable Inputs Unobservable Inputs Value (Level 1) (Level 2) (Level 3) Assets: Investments held in Trust Account – U.S. Treasury Bills 0 $ 276,000,000 $ — $ — Liabilities: Private Warrants — — — 8,092,670 Public Warrants 1 — — 10,889,321 |
Schedule of quantitative information regarding Level 3 fair value measurements inputs | March 9, 2021 (Initial Input Measurement) March 31, 2021 Risk-free interest rate 1.09 % 1.22 % Expected term (years) 6.31 6.25 Expected volatility 24.3 % 24.4 % Exercise price $ 11.50 $ 11.50 |
Schedule of change in the fair value of the warrant liabilities | Fair value at issuance March 9 2021 $ 18,322,046 Change in fair value 659,945 Fair Value at March 31, 2021 $ 18,981,991 |
Organization and Business Ope_2
Organization and Business Operations (Details) - USD ($) | Mar. 09, 2021 | Mar. 31, 2021 | Apr. 12, 2021 |
Subsidiary, Sale of Stock [Line Items] | |||
Proceeds from issuance initial public offering | $ 275,552,107 | ||
Price of warrant | $ 0.01 | ||
Proceeds from issuance of warrants | $ 7,520,000 | ||
Transaction costs | $ 15,627,893 | ||
Underwriting discount | 5,520,000 | ||
Deferred underwriting discount | 9,660,000 | 9,660,000 | |
Other offering costs | 447,893 | ||
Transaction costs | 606,622 | 606,622 | |
Transaction costs included in equity | $ 15,021,271 | 15,021,271 | |
Investments and marketable securities held in Trust Account | 276,000,000 | ||
Redemption of shares calculated based on business days prior to consummation of business combination (in days) | 2 days | ||
Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent) | 100.00% | ||
Minimum net tangible assets upon consummation of the business combination | $ 5,000,001 | ||
Threshold business days for redemption of public shares | 10 days | ||
Maximum net interest to pay dissolution expenses | $ 100,000 | ||
Cash operating bank account | 999,748 | ||
Working capital | 1,200,000 | ||
Sponsor | |||
Subsidiary, Sale of Stock [Line Items] | |||
Aggregate purchase price | 25,000 | ||
Maximum borrowing capacity of related party unsecured promissory note | 300,000 | ||
Repayment of unsecured promissory note - related party | $ 300,000 | ||
Working Capital Loans | |||
Subsidiary, Sale of Stock [Line Items] | |||
Outstanding balance of related party note | $ 38,252 | ||
Warrants | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of units issued | 27,600,000 | ||
Private Warrants | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of warrants to purchase shares issued | 5,013,333 | 6,900,000 | |
Price of warrant | $ 1.50 | ||
Proceeds from issuance of warrants | $ 7,520,000 | ||
IPO | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of units issued | 27,600,000 | ||
Unit price per unit | $ 10 | ||
Gross proceeds from sale of units | $ 276,000,000 | ||
Number of warrants to purchase shares issued | 5,013,333 | ||
Transaction costs included in equity | $ 15,627,893 | ||
Investments and marketable securities held in Trust Account | $ 276,000,000 | ||
Private Placement | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of warrants to purchase shares issued | 5,013,333 | ||
Price of warrant | $ 1.50 | ||
Proceeds from issuance of warrants | $ 7,520,000 | ||
Private Placement | Warrants | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of warrants to purchase shares issued | 1 | ||
Price of warrant | $ 11.50 | ||
Over-allotment option | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of units issued | 3,600,000 | ||
Purchase price, per unit | $ 10 | ||
Gross proceeds from sale of units | $ 276,000,000 |
Revision of Financial Stateme_3
Revision of Financial Statements - Additional (Details) - shares | Apr. 12, 2021 | Mar. 31, 2021 |
IPO | ||
Number of warrants to purchase shares issued | 5,013,333 | |
Private Warrants | ||
Number of warrants to purchase shares issued | 6,900,000 | 5,013,333 |
Revision of Financial Stateme_4
Revision of Financial Statements - the financial statements been restated (Details) - USD ($) | Mar. 09, 2021 | Mar. 31, 2021 | Dec. 31, 2020 |
Warranty liability | $ 18,322,046 | $ 18,981,991 | |
Liabilities | 28,734,766 | 28,903,707 | $ 275,264 |
Additional paid-in capital | 5,921,582 | 6,963,704 | 24,310 |
Accumulated deficit | (922,581) | (1,964,715) | (1,302) |
Total Stockholder's Equity | 5,000,007 | 5,000,003 | $ 23,698 |
As Previously Reported | |||
Liabilities | 10,412,720 | ||
Additional paid-in capital | 5,002,908 | ||
Accumulated deficit | (3,728) | ||
Total Stockholder's Equity | 5,000,003 | ||
Adjustment | |||
Warranty liability | 18,322,046 | ||
Liabilities | 18,322,046 | ||
Additional paid-in capital | 918,674 | ||
Accumulated deficit | (918,853) | ||
Total Stockholder's Equity | 4 | ||
Class A Common Stock | |||
Class A common stock | 316 | ||
Total Stockholder's Equity | $ 324 | ||
Class A Common Stock | As Previously Reported | |||
Class A common stock | 133 | ||
Class A Common Stock | Adjustment | |||
Class A common stock | 183 | ||
Class A Common Stock Subject to Redemption | |||
Class A common stock subject to possible redemption, | 244,358,910 | ||
Class A Common Stock Subject to Redemption | As Previously Reported | |||
Class A common stock subject to possible redemption, | 262,680,960 | ||
Class A Common Stock Subject to Redemption | Adjustment | |||
Class A common stock subject to possible redemption, | $ (18,322,050) |
Significant Accounting Polici_4
Significant Accounting Policies (Details) - USD ($) | Mar. 09, 2021 | Mar. 31, 2021 |
Cash equivalents | $ 1,000,000 | |
Transaction costs included in equity | $ 15,021,271 | 15,021,271 |
Transaction Costs Allocated To Warrant Liability | 606,622 | 606,622 |
Marketable securities held in Trust Account | 276,000,000 | 276,000,000 |
Credit Concentration Risk | ||
Federal depository insurance coverage | 250,000 | |
IPO | ||
offering costs | 15,627,893 | |
underwriting discount | 5,520,000 | 5,520,000 |
deferred underwriting discount | $ 9,660,000 | 9,660,000 |
other offering costs | 447,893 | |
Transaction costs included in equity | $ 15,627,893 |
Significant Accounting Polici_5
Significant Accounting Policies - Reconciliation of Net Loss per Common Stock (Details) | 3 Months Ended |
Mar. 31, 2021USD ($)$ / sharesshares | |
Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] | |
Net Income (Loss) Attributable to Parent | $ (1,963,413) |
Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 6,900,000 |
Earnings Per Share, Basic and Diluted | $ / shares | $ (0.28) |
Common Stock Subject To Possible Redemption [Member] | |
Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] | |
Accretion of interest income on cash held in trust | $ 0 |
Less: interest available to be withdrawn for payment of taxes | $ 0 |
Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 27,600,000 |
Earnings Per Share, Basic and Diluted | $ / shares | $ 0 |
Non Redeemable Common Stock | |
Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] | |
Net Income (Loss) Attributable to Parent | $ (1,963,413) |
Less: interest available to be withdrawn for payment of taxes | (1,963,413) |
Net income allocable to Class A common stock subject to possible redemption | $ 0 |
Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 6,900,000 |
Earnings Per Share, Basic and Diluted | $ / shares | $ (0.28) |
Initial Public Offering (Detail
Initial Public Offering (Details) - USD ($) | Mar. 09, 2021 | Mar. 31, 2021 |
Subsidiary, Sale of Stock [Line Items] | ||
Number of warrants in a unit | 0.25 | |
Class of Warrant or Right, Price of Warrants or Rights | $ 0.01 | |
Class A Common Stock | ||
Subsidiary, Sale of Stock [Line Items] | ||
Number of shares in a unit | 1 | |
IPO | ||
Subsidiary, Sale of Stock [Line Items] | ||
Number of units issued | 27,600,000 | |
Gross proceeds from sale of units | $ 276,000,000 | |
Underwriting fee | 5,520,000 | $ 5,520,000 |
Additional fee | $ 9,660,000 | $ 9,660,000 |
IPO | Public Warrants | ||
Subsidiary, Sale of Stock [Line Items] | ||
Exercise price of warrants | $ 11.50 | |
Over-allotment option | ||
Subsidiary, Sale of Stock [Line Items] | ||
Number of units issued | 3,600,000 | |
Purchase price, per unit | $ 10 | |
Gross proceeds from sale of units | $ 276,000,000 |
Private Placement (Details)
Private Placement (Details) - USD ($) | Mar. 09, 2021 | Mar. 31, 2021 | Apr. 12, 2021 |
Subsidiary, Sale of Stock [Line Items] | |||
Price of warrants | $ 0.01 | ||
Proceeds from issuance of warrants | $ 7,520,000 | ||
Private Warrants | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of warrants to purchase shares issued | 5,013,333 | 6,900,000 | |
Price of warrants | $ 1.50 | ||
Proceeds from issuance of warrants | $ 7,520,000 | ||
Number of shares per warrant | 1 | ||
Exercise price of warrant | $ 11.50 | ||
Private Placement | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of warrants to purchase shares issued | 5,013,333 | ||
Price of warrants | $ 1.50 | ||
Proceeds from issuance of warrants | $ 7,520,000 |
Related Party Transactions - Fo
Related Party Transactions - Founder Shares (Details) | Mar. 09, 2021USD ($) | Feb. 28, 2021shares | Dec. 31, 2020USD ($)$ / sharesshares | Mar. 31, 2021USD ($)$ / sharesshares | Oct. 31, 2020shares |
Class B Common Stock | |||||
Related Party Transaction [Line Items] | |||||
Common shares, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 | |||
Class B Common Stock | Over-allotment option | |||||
Related Party Transaction [Line Items] | |||||
Shares no longer subject to forfeiture | 900,000 | ||||
Sponsor | |||||
Related Party Transaction [Line Items] | |||||
Aggregate purchase price | $ | $ 25,000 | ||||
Sponsor | Class B Common Stock | |||||
Related Party Transaction [Line Items] | |||||
Common shares, par value (in dollars per share) | $ / shares | $ 0.0001 | ||||
Share dividend | 0.2 | ||||
Aggregate number of shares owned | 6,900,000 | ||||
Restrictions on transfer period of time after business combination completion | 1 year | ||||
Founder Shares | Sponsor | Class B Common Stock | |||||
Related Party Transaction [Line Items] | |||||
Consideration received | $ | $ 25,000 | ||||
Consideration received, shares | 5,750,000 | ||||
Shares subject to forfeiture | 6,900,000 | ||||
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares | $ 12 | ||||
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | $ | 20 | ||||
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | $ | 30 | ||||
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences | 150 days | ||||
Founder Shares | Sponsor | Class B Common Stock | Over-allotment option | |||||
Related Party Transaction [Line Items] | |||||
Shares subject to forfeiture | 900,000 |
Related Party Transactions - Ad
Related Party Transactions - Additional Information (Details) - USD ($) | Mar. 09, 2021 | Mar. 31, 2021 | Dec. 31, 2020 |
Related Party Transaction [Line Items] | |||
Price of warrant | $ 0.01 | ||
Sponsor | |||
Related Party Transaction [Line Items] | |||
Repayment of promissory note - related party | $ 300,000 | ||
Promissory Note with Related Party | |||
Related Party Transaction [Line Items] | |||
Maximum borrowing capacity of related party promissory note | $ 300,000 | ||
Repayment of promissory note - related party | $ 1,000,000 | ||
Administrative Support Agreement | Sponsor | |||
Related Party Transaction [Line Items] | |||
Expenses per month | $ 10,000 | ||
Related Party Loans | |||
Related Party Transaction [Line Items] | |||
Price of warrant | $ 1.50 | ||
Related Party Loans | Working capital loans warrant | |||
Related Party Transaction [Line Items] | |||
Maximum borrowing capacity of related party promissory note | $ 38,252 | ||
Loan conversion agreement warrant | $ 1,500,000 |
Commitments and Contingencies (
Commitments and Contingencies (Details) - USD ($) | Mar. 31, 2021 | Mar. 09, 2021 |
Commitments and Contingencies | ||
Deferred fee per unit | $ 3.5 | |
Deferred underwriting fee payable | $ 9,660,000 | $ 9,660,000 |
Stockholder's Equity - Preferre
Stockholder's Equity - Preferred Stock Shares (Details) - $ / shares | Mar. 31, 2021 | Mar. 09, 2021 | Dec. 31, 2020 |
Stockholder's Equity | |||
Preferred shares, shares authorized | 1,000,000 | 1,000,000 | |
Preferred stock, par value, (per share) | $ 0.0001 | $ 0.0001 | |
Preferred shares, shares issued | 0 | 0 | 0 |
Preferred shares, shares outstanding | 0 | 0 | 0 |
Stockholder's Equity - Common S
Stockholder's Equity - Common Stock Shares (Details) | 3 Months Ended | |
Mar. 31, 2021$ / sharesshares | Dec. 31, 2020$ / sharesshares | |
Class A Common Stock | ||
Class of Stock [Line Items] | ||
Common shares, shares authorized (in shares) | 280,000,000 | 280,000,000 |
Common shares, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 |
Common shares, shares issued (in shares) | 3,246,421 | 0 |
Common shares, shares outstanding (in shares) | 3,246,421 | 0 |
Class A common stock subject to possible redemption, outstanding (in shares) | 24,353,579 | 0 |
Class A Common Stock Subject to Redemption | ||
Class of Stock [Line Items] | ||
Class A common stock subject to possible redemption, issued (in shares) | 24,353,579 | 0 |
Class A Common Stock Not Subject to Redemption | ||
Class of Stock [Line Items] | ||
Common shares, shares authorized (in shares) | 280,000,000 | 280,000,000 |
Common shares, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 |
Common shares, shares issued (in shares) | 3,246,421 | |
Common shares, shares outstanding (in shares) | 3,246,421 | 0 |
Class B Common Stock | ||
Class of Stock [Line Items] | ||
Common shares, shares authorized (in shares) | 20,000,000 | 20,000,000 |
Common shares, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 |
Common shares, shares issued (in shares) | 6,900,000 | 6,900,000 |
Common shares, shares outstanding (in shares) | 6,900,000 | 6,900,000 |
Ratio to be applied to the stock in the conversion | 20 |
Recurring Fair Value Measurem_3
Recurring Fair Value Measurements (Details) - USD ($) | Mar. 31, 2021 | Mar. 09, 2021 |
Assets: | ||
Cash held in the Trust Account | $ 276,000,000 | |
Marketable securities held in Trust Account | 276,000,000 | $ 276,000,000 |
Liabilities, Fair Value Disclosure [Abstract] | ||
Warranty liability | 18,981,991 | $ 18,322,046 |
Recurring | Public Warrants | ||
Liabilities, Fair Value Disclosure [Abstract] | ||
Warranty liability | 1 | |
U.S. Treasury Bills | Recurring | ||
Assets: | ||
Cash held in the Trust Account | 0 | |
Level 1 | U.S. Treasury Bills | Recurring | ||
Assets: | ||
Cash held in the Trust Account | 276,000,000 | |
Level 3 | Recurring | Private Warrants | ||
Liabilities, Fair Value Disclosure [Abstract] | ||
Warranty liability | 8,092,670 | |
Level 3 | Recurring | Public Warrants | ||
Liabilities, Fair Value Disclosure [Abstract] | ||
Warranty liability | $ 10,889,321 |
Recurring Fair Value Measurem_4
Recurring Fair Value Measurements - Level 3 Fair Value Measurements Inputs (Details) | Mar. 31, 2021$ / sharesUSD ($) | Mar. 09, 2021$ / sharesUSD ($) |
Risk-free interest rate | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative Liability, Measurement Input | 1.22 | 1.09 |
Expected term (years) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative Liability, Measurement Input | $ | 6.25 | 6.31 |
Expected volatility | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative Liability, Measurement Input | 24.4 | 24.3 |
Exercise price | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative Liability, Measurement Input | $ / shares | 11.50 | 11.50 |
Recurring Fair Value Measurem_5
Recurring Fair Value Measurements - Change in the Fair Value of the Warrant Liabilities (Details) - USD ($) | 1 Months Ended | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2021 | Mar. 09, 2021 | |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Warrant liabilities at (inception) | $ 18,322,046 | ||
Warrant liabilities at end of period | 18,981,991 | $ 18,981,991 | |
Warranty liability | 18,981,991 | 18,981,991 | $ 18,322,046 |
Change in fair value of warrant liabilities | $ 659,945 | $ 659,945 |